KLK3 and prostate cancer: Dwek et al. demonstrated that serum α1,2-Fucosylated PSA was significantly higher in men with prostate cancer than in men with BPH using an enzyme-linked immunosorbent lectin assay with Ulex europaeus (UEA-1) [85].